• Mashup Score: 0
    The Indispensable Art Of Push Back - 10 month(s) ago

    A physics lesson in navigating social discourse.

    Source: Medium
    Categories: Future of Medicine, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of JohnNosta
      JohnNosta

      "Too often, fervent ideas and passionate conversations are mislabeled and dismissed as aggressive or confrontational, which can be used as a tool for suppression." https://t.co/oxr34PYZ9Y #science #medicine #politics #debate @jordanbpeterson https://t.co/HEGLDHid7n

  • Mashup Score: 5
    AUA 2023: Bladder Preservation in Muscle Invasive Bladder Cancer: Myth or Reality - 12 month(s) ago

    AUA 2023 muscle invasive bladder cancer, trimodality bladder preservation, Neoadjuvant chemotherapy followed by radical cystectomy, Radical cystectomy, aggressive TURBT and salvage cystectomy, cT2-T4N0M0 bladder urothelial carcinoma.

    Source: www.urotoday.com
    Categories: General Medicine News, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of urotoday
      urotoday

      Bladder preservation in #MIBC: myth or reality. #AUA23 #debate moderated by @shilpaonc @CleClinicMD. Arguments from Jason Efstathiou, MD @MGHMedicine and @MariaJRibal @hospitalclinic. Written coverage by @zklaassen_md > https://t.co/uyo1jVJ6x5 @IBCG_BladderCA @AmerUrological https://t.co/NjrUiZbmDZ

  • Mashup Score: 0
    AUA 2023: Optimizing BCG Therapy/Managing BCG Toxicity - 12 month(s) ago

    AUA 2023 optimizing BCG therapy and managing BCG toxicity, urothelial carcinoma, bladder cancer, EORTC 30911, optimizing BCG therapy, NIMBUS clinical trial,

    Source: www.urotoday.com
    Categories: General Medicine News, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of urotoday
      urotoday

      Optimizing BCG therapy/managing BCG toxicity. #AUA23 #debate moderated by @JoshMeeks @NUFeinbergMed. Arguments from @WesKassouf @mcgillu and @bkonety @AllinaHealth. Written coverage by @zklaassen_md @GACancerCenter > https://t.co/UYVoxi2pCd @AmerUrological @IBCG_BladderCA https://t.co/zgzXVQB4nF

  • Mashup Score: 1
    AUA 2023: Very High Risk NMIBC: Radical Cystectomy or Intravesical Therapy - 12 month(s) ago

    AUA 2023 radical cystectomy or intravesical therapy for very high risk non-muscle invasive bladder cancer (NMIBC), high grade T1 urothelial carcinoma, kidney stones, pT1 high grade disease.

    Source: www.urotoday.com
    Categories: General Medicine News, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of urotoday
      urotoday

      Very high-risk #NMIBC: radical cystectomy or intravesical therapy. #AUA23 #debate moderated by @spsutkaMD with arguments from Seth Lerner, MD, FACS @bcmhouston and J. Alfred Witjes, MD, PhD @radboudumc. Written coverage by @zklaassen_md > https://t.co/lZhsu9tIWT @IBCG_BladderCA https://t.co/xgY8nd4qya

  • Mashup Score: 2
    AUA 2023: Pathology or 'Markers': What is More Important? - 12 month(s) ago

    AUA 2023, bladder cancer, SWOG S1314 COXEN clinical trial, bladder urothelial cancer with micropapillary histology, bladder cancer pathology,  trans urethral resection of bladder tumor (TURBT), high grade urothelial carcinoma, variant histology micropapillary lymphovascular invasion, muscularis propria involvement.

    Source: www.urotoday.com
    Categories: General Medicine News, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of urotoday
      urotoday

      Pathology or 'Markers': What is more important? #AUA23 #Debate with @CharlesG4022 @MDAndersonNews and @djmcconkey @JHBladderCancer. Written coverage by @zklaassen_md @GACancerCenter > https://t.co/R1dePaWmmr @ylotan @AmerUrological https://t.co/4Kc4bPOHfK

  • Mashup Score: 10
    We need a much more sophisticated debate about AI - 1 year(s) ago

    The writer is a barrister and the author of ‘ The Digital Republic: On Freedom and Democracy in the 21st Century’ The public debate around artificial intelligence sometimes seems to be playing out in two alternate realities. In one, AI is regarded as a remarkable but potentially dangerous step forward in human affairs, necessitating new and careful forms of governance.

    Source: Financial Times
    Categories: Future of Medicine, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of ahier
      ahier

      RT @SpirosMargaris: We need a much more sophisticated #debate about #AI https://t.co/tmAsGdbBol #fintech #ArtificialIntelligence #Machin…

  • Mashup Score: 3
    Debate: PARP Inhibitors Only in Selected mCRPC Patients APCCC 2022 Presentation - Johann de Bono - 1 year(s) ago

    At the 2022 Advanced Prostate Cancer Consensus Conference, Johann de Bono presents the role of PARP inhibitors for metastatic castration-resistant prostate cancer (mCRPC) patients focusing on the case for a selected, judicious use of PARP inhibitors in this setting. Biographies: Johann de Bono, MD, PhD, Professor of Cancer Research and a Professor in Experimental Cancer Medicine at The…

    Source: UroToday
    Categories: General Medicine News, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of urotoday
      urotoday

      #Debate: PARP inhibitors only in selected #mCRPC patients. #APCCC22 presentation by @jodebon @ICR_London. #WatchNow on UroToday > https://t.co/kkcKH8YEgD @APCCC_Lugano @silkegillessen @AOmlin @heatherhcheng https://t.co/3zPE9MCPNK

Load More